Abstract:Genetic mutations have long been implicated in epilepsy, particularly in genes that encode ion channels and neurotransmitter receptors. Among some of those identified are voltage-gated sodium, potassium and calcium channels, and ligand-gated gamma-aminobutyric acid (GABA), neuronal nicotinic acetylcholine (CHRN), and glutamate receptors, making them key therapeutic targets. In this chapter we discuss the use of automated electrophysiological technologies to examine the impact of gene defects in two potassium channels associated with different epilepsy syndromes. The hKCNC1 gene encodes the voltage-gated potassium channel hKV3.1, and mutations in this gene cause progressive myoclonus epilepsy (PME) and ataxia due to a potassium channel mutation (MEAK). The hKCNT1 gene encodes the weakly voltage-dependent sodium-activated potassium channel hKCNT1, and mutations in this gene cause a wide spectrum of seizure disorders, including severe autosomal dominant sleep-related hypermotor epilepsy (ADSHE) and epilepsy of infancy with migrating focal seizures (EIMFS), both conditions associated with drug-resistance. Importantly, both of these potassium channels play vital roles in regulating neuronal excitability. Since its discovery in the late nineteen seventies, the patch-clamp technique has been regarded as the bench-mark technology for exploring ion channel characteristics. In more recent times, innovations in automated patch-clamp technologies, of which there are many, are enabling the study of ion channels with much greater productivity that manual systems are capable of. Here we describe aspects of Nanion NPC-16 Patchliner, examining the effects of temperature on stably and transiently transfected mammalian cells, the latter of which for most automated systems on the market is quite challenging. Remarkable breakthroughs in the development of other automated electrophysiological technologies, such as multielectrode arrays that support extracellular signal recordings, provide additional features to examine network activity in the area of ion channel research, particularly epilepsy. Both of these automated technologies enable the acquisition of consistent, robust, and reproducible data. Numerous systems have been developed with very similar capabilities, however, not all the systems on the market are adapted to work with primary cells, particularly neurons that can be problematic. This chapter also showcases methods that demonstrate the versatility of Nanion NPC-16 Patchliner and the Multi Channel Systems (MCS) multielectrode array (MEA) assay for acutely dissociated murine primary cortical neurons, enabling the study of potassium channel mutations implicated in severe refractory epilepsies.

Approaches for the discovery of drugs that target K Na 1.1 channels in KCNT1-associated epilepsy

Discovery of Potent and Selective Blockers Targeting the Epilepsy-Associated K Na 1.1 Channel

Discovery of Potent and Selective Blockers Targeting the Epilepsy-Associated KNa1.1 Channel.

In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel

Preclinical insights into therapeutic targeting of KCC2 for disorders of neuronal hyperexcitability

Potassium channels and epilepsy

KCNT1 Channel Blockers: A Medicinal Chemistry Perspective

Voltage-gated potassium channels and genetic epilepsy

Functional characterization and in vitro pharmacological rescue of KCNQ2 pore mutations associated with epileptic encephalopathy

Identifying mutations in epilepsy genes: Impact on treatment selection

Gene therapy for targeting a prenatally enriched potassium channel associated with severe childhood epilepsy and premature death

Efficacy of anti-seizure medications and alternative therapies (ketogenic diet, CBD, and quinidine) in KCNT1-related epilepsy: A systematic review

Neuronal K+-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment

Treatment Responsiveness in KCNT1-Related Epilepsy

Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs

Utilising Automated Electrophysiological Platforms in Epilepsy Research

Carvedilol inhibits neuronal hyperexcitability caused by epilepsy‐associated KCNT1 mutations

The Current Precision Medicine Approaches in Genetic Epilepsies

KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases

Pharmacogenetic and Case-Control Study on Potassium Channel Related Gene Variants and Genetic Generalized Epilepsy

Isoform-specific Prolongation of Kv7 (KCNQ) Potassium Channel Opening Mediated by New Molecular Determinants for Drug-Channel Interactions